Literature DB >> 9723655

The role of IL-13 and its receptor in allergy and inflammatory responses.

J E de Vries1.   

Abstract

IL-13 is a cytokine that is produced by different T-cell subsets and dendritic cells. IL-13 shares many biologic activities with IL-4. This is due to the fact that IL-13- and IL-4-receptor complexes share the IL-4-receptor alpha-chain, which is important for signal transduction. T cells do not express functional IL-13 receptors. This is the reason why IL-13, in contrast to IL-4, fails to induce TH2-cell differentiation, one of the hallmarks of the allergic response. However, IL-13 is required for optimal induction of IgE synthesis, particularly in situations in which IL-4 production is low or absent. On the other hand, IL-13 inhibits proinflammatory cytokine and chemokine production in vitro and has potent antiinflammatory activities in vivo. From these observations, it can be concluded that IL-13 is an antiinflammatory cytokine that plays a unique role in the induction and maintenance of IgE production and IgE-mediated allergic responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723655     DOI: 10.1016/s0091-6749(98)70080-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  72 in total

1.  Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.

Authors:  Ivan Rajkovic; Ana Dragicevic; Sasa Vasilijic; Biljana Bozic; Tanja Dzopalic; Sergej Tomic; Ivana Majstorovic; Dragana Vucevic; Jelena Djokic; Bela Balint; Miodrag Colic
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 3.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

4.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Authors:  J Corne; G Chupp; C G Lee; R J Homer; Z Zhu; Q Chen; B Ma; Y Du; F Roux; J McArdle; A B Waxman; J A Elias
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

6.  Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.

Authors:  Masato Komai; Hiroyuki Tanaka; Taisei Masuda; Koichi Nagao; Masayuki Ishizaki; Masatsugu Sawada; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro.

Authors:  B Heydenreich; I Bellinghausen; L Lund; H Henmar; G Lund; P Adler Würtzen; J Saloga
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

8.  Comprehensive clarification of two paralogous interleukin 4/13 loci in teleost fish.

Authors:  Maki Ohtani; Nobuhiro Hayashi; Keiichiro Hashimoto; Teruyuki Nakanishi; Johannes Martinus Dijkstra
Journal:  Immunogenetics       Date:  2008-06-17       Impact factor: 2.846

Review 9.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

10.  Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.

Authors:  Kate L Tomlinson; Gareth C G Davies; Daniel J Sutton; Roger T Palframan
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.